Heidi Schultz is a Principal Scientist at Ferring Pharmaceuticals, where they focus on drug development in the pharmaceutical industry. With over ten years of experience in R&D, they have specialized in immunology, particularly in in vitro assays, mechanism of action, and immunogenicity. Previously, Heidi served as a Principal Scientist at Dragonfly Therapeutics, managing research and development for innovative antibody-based drugs. They hold a Master's degree in Human Biology and a Bachelor's degree in Biology from Københavns Universitet.
This person is not in any teams
This person is not in any offices